Stay updated with breaking news from Distant Spread. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced positive topline results from the second of three Phase 3 clinical studies...
- Provides Revance entry into the $2.5 billion U.S. therapeutic neuromodulator market.1 - Approval expands the DAXXIFY® label to include efficacy data over the 52-week ASPEN repeat dose clinical... -Today at 08:04 am- MarketScreener
Received FDA approval for DAXXIFY™ (DaxibotulinumtoxinA-lanm) for injection for the treatment of glabellar linesQ3 total revenue of $29.0 million, a YoY increase of 47% with RHA® Collection revenue of $26.1 million, a YoY increase of 43%Aesthetic accounts across products and services totaled over 4,500 at quarter-en...
/PRNewswire/ -- Galderma announced today its upcoming participation in New York City's official LGBTQIA+ Pride (NYC Pride) event. The company's aesthetics...
/PRNewswire/ -- Galderma announced the presentation of data supporting its aesthetics portfolio and pipeline at the virtual American Society for Dermatologic...